🚀 VC round data is live in beta, check it out!
Bioneer Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bioneer and similar public comparables like Lucid Diagnostics, OraSure, Nano X Imaging, Vuno and more.
Bioneer Overview
About Bioneer
Bioneer Corp engages in the manufacture and sale of biotechnological products in South Korea. It offers deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits, DNA and ribonucleic acid (RNA) amplification products, human diagnostics kits, veterinary diagnostics kits, among others.
Founded
1992
HQ
Employees
N/A
Website
Financials (FY)
EV
$224M
Bioneer Financials
Bioneer reported last fiscal year revenue of $223M and EBITDA of $16M.
In the same fiscal year, Bioneer generated $174M in gross profit, $16M in EBITDA, and had net loss of ($2M).
Bioneer P&L
In the most recent fiscal year, Bioneer reported revenue of $223M and EBITDA of $16M.
Bioneer expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $223M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $174M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 78% | XXX | XXX | XXX |
| EBITDA | — | XXX | $16M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 4% | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (1%) | XXX | XXX | XXX |
| Net Debt | — | — | $38M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bioneer Stock Performance
Bioneer has current market cap of $214M, and enterprise value of $224M.
Market Cap Evolution
Bioneer's stock price is $8.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $224M | $214M | 11.1% | XXX | XXX | XXX | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBioneer Valuation Multiples
Bioneer trades at 1.0x EV/Revenue multiple, and 14.1x EV/EBITDA.
Bioneer Financial Valuation Multiples
As of April 18, 2026, Bioneer has market cap of $214M and EV of $224M.
Equity research analysts estimate Bioneer's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bioneer has a P/E ratio of (112.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $214M | XXX | $214M | XXX | XXX | XXX |
| EV (current) | $224M | XXX | $224M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 14.1x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 23.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.3x | XXX | XXX | XXX |
| P/E | — | XXX | (112.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 104.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bioneer Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bioneer Margins & Growth Rates
Bioneer's revenue in the last fiscal year grew by 12%.
Bioneer Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (945%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 58% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 74% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bioneer Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bioneer | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucid Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| OraSure | XXX | XXX | XXX | XXX | XXX | XXX |
| Nano X Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| Vuno | XXX | XXX | XXX | XXX | XXX | XXX |
| Detection Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bioneer M&A Activity
Bioneer acquired XXX companies to date.
Last acquisition by Bioneer was on XXXXXXXX, XXXXX. Bioneer acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bioneer
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBioneer Investment Activity
Bioneer invested in XXX companies to date.
Bioneer made its latest investment on XXXXXXXX, XXXXX. Bioneer invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bioneer
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bioneer
| When was Bioneer founded? | Bioneer was founded in 1992. |
| Where is Bioneer headquartered? | Bioneer is headquartered in South Korea. |
| Who is the CEO of Bioneer? | Bioneer's CEO is Han-Oh Park. |
| Is Bioneer publicly listed? | Yes, Bioneer is a public company listed on Korea Exchange. |
| What is the stock symbol of Bioneer? | Bioneer trades under 064550 ticker. |
| When did Bioneer go public? | Bioneer went public in 2005. |
| Who are competitors of Bioneer? | Bioneer main competitors are Lucid Diagnostics, OraSure, Nano X Imaging, Vuno. |
| What is the current market cap of Bioneer? | Bioneer's current market cap is $214M. |
| What is the current revenue of Bioneer? | Bioneer's last fiscal year revenue is $223M. |
| What is the current EV/Revenue multiple of Bioneer? | Current revenue multiple of Bioneer is 1.0x. |
| Is Bioneer profitable? | No, Bioneer is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.